Delivery Order SPE2DR25D1022-SPE2DR26FRD2N

The Defense Logistics Agency issued a $59,072.02 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Ultomiris 1,100 mg/11 ml vials, with an ultimate completion date of April 15, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. Pricing...

<p>The Defense Logistics Agency issued a $28,251.84 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Ultomiris 1,100 mg/11 mL vials under firm fixed-price terms.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is April 15, 2026. No set-aside applies to this order.</p>

<p>The Defense Logistics Agency issued a $28,251.84 delivery order to AmerisourceBergen Drug Corp on March 31, 2026, for supply of Ultomiris 1,100 mg/11 ml vials.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is April 21, 2026. Pricing is firm fixed price. No set-aside applies.</p>

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 13, 2026, for Ultomiris (pecirilumab) 300 mg/3 mL vials, with a ceiling value of $56,503.48 under firm fixed-price terms. Place of performance is Conshohocken, PA. The order has an ultimate completion date of May 4, 2026. No set-aside was applied. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up...

<p>The Defense Logistics Agency issued a $56,503.48 delivery order to Amerisourcebergen Drug Corp on March 17, 2026, for Ultomiris 300 mg/3 mL vials under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion on April 7, 2026. No set-aside was used in the award.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, with a ceiling value of $51,366.80 for Ultomiris 300 mg/3 ml vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed price with an ultimate completion date of March 11, 2026.</p>

The Defense Logistics Agency issued a $28,251.81 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for Ultomiris (periphreral) 1,100 mg/11 ml vial pharmaceutical supply. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure and an ultimate completion date of May 20, 2026. No set-aside was used. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution, competing on...

The Defense Logistics Agency awarded a delivery order valued at $10,273.36 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Ultomiris 300 mg/3 ml vials. This competitively awarded, firm fixed price contract is scheduled for completion by January 27, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger...

The Defense Logistics Agency awarded a $50,634.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561498304 Ultomiris 300 mg/3 ml vials. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of DLA and Department of Defense requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with work concluding by August 2, 2023. No...

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 2, 2026, for Ultomiris (pegloticase) 1,100 mg/11 mL vials with a ceiling value of $28,251.84. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare systems globally. Place of performance is Conshohocken, PA. The delivery order carries a firm fixed price...